nach oben

Current Pain and Headache Reports

Erschienen in:

01.09.2016 | Imaging (L Mechtler, Section Editor)

Imaging of MELAS

verfasst von: Konark Malhotra, David S. Liebeskind

Erschienen in: Current Pain and Headache Reports | Ausgabe 9/2016

Einloggen, um Zugang zu erhalten

Abstract

Mitochondrial diseases are multisystem disorders that frequently involve the central nervous system. The clinical presentation of these disorders may be challenging to differentiate from cerebrovascular disorders. Various imaging techniques are now available that provide a wide range of imaging modalities during initial clinical evaluation and throughout the disease course. Recent technological advancements have introduced advanced neuroimaging modalities that provide detailed information of metabolic disorders at the tissue level. Imaging findings, though diverse, usually have characteristic features that support differentiating these disorders from vascular syndromes. This article provides an overview of various neuroimaging modalities available along with the advent of new imaging techniques being utilized in these disorders.

Pavlakis SG, Phillips PC, DiMauro S, De Vivo DC, Rowland LP. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann Neurol. 1984;16(4):481–8. doi:10.1002/ana.410160409.CrossRefPubMed

DiMauro S, Schon EA. Mitochondrial disorders in the nervous system. Annu Rev Neurosci. 2008;31:91–123. doi:10.1146/annurev.neuro.30.051606.094302.CrossRefPubMed

DiMauro S, Schon EA. Mitochondrial respiratory-chain diseases. N Engl J Med. 2003;348(26):2656–68. doi:10.1056/NEJMra022567.CrossRefPubMed

Iizuka T, Sakai F. Pathogenesis of stroke-like episodes in MELAS: analysis of neurovascular cellular mechanisms. Curr Neurovasc Res. 2005;2(1):29–45.CrossRefPubMed

Malhotra K, Liebeskind DS. Imaging in Endovascular Stroke Trials. J Neuroimaging. 2015;25(4):517–27. doi:10.1111/jon.12272.CrossRefPubMedPubMedCentral

Goto Y, Horai S, Matsuoka T, Koga Y, Nihei K, Kobayashi M, et al. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): a correlative study of the clinical features and mitochondrial DNA mutation. Neurology. 1992;42(3 Pt 1):545–50.CrossRefPubMed

7.••

Yoshida T, Ouchi A, Miura D, Shimoji K, Kinjo K, Sueyoshi T, et al. MELAS and reversible vasoconstriction of the major cerebral arteries. Int Med (Tokyo, Japan). 2013;52(12):1389–92.CrossRef

8.••

Yeh HL, Chen YK, Chen WH, Wang HC, Chiu HC, Lien LM, et al. Perfusion status of the stroke-like lesion at the hyperacute stage in MELAS. Brain Dev. 2013;35(2):158–64. doi:10.1016/j.braindev.2012.03.017.CrossRefPubMed

Ito H, Mori K, Kagami S. Neuroimaging of stroke-like episodes in MELAS. Brain Dev. 2011;33(4):283–8. doi:10.1016/j.braindev.2010.06.010.CrossRefPubMed

10.

Haas R, Dietrich R. Neuroimaging of mitochondrial disorders. Mitochondrion. 2004;4(5–6):471–90. doi:10.1016/j.mito.2004.07.008.CrossRefPubMed

11.

Ito H, Mori K, Harada M, Minato M, Naito E, Takeuchi M, et al. Serial brain imaging analysis of stroke-like episodes in MELAS. Brain Dev. 2008;30(7):483–8. doi:10.1016/j.braindev.2008.01.003.CrossRefPubMed

12.

Allard JC, Tilak S, Carter AP. CT and MR of MELAS syndrome. AJNR Am J Neuroradiol. 1988;9(6):1234–8.PubMed

13.

Johnson EC, West TW, Ko NU, Strober JB. A 41-year-old man with new headache and altered mental status. Neurohospitalist. 2011;1(1):48–54. doi:10.1177/1941875210385948.CrossRefPubMedPubMedCentral

14.

Lazzaro MA, Malhotra K, Mohammad YM. The role of antithrombotics in secondary stroke prevention. Semin Neurol. 2010;30(5):492–500. doi:10.1055/s-0030-1268860.CrossRefPubMed

15.

Finsterer J, Barton P. Regression of stroke-like lesions in MELAS-syndrome after seizure control. Epileptic Disord. 2010;12(4):330–4. doi:10.1684/epd.2010.0338.PubMed

16.

Carolei A, Sacco S. Headache attributed to arteritis, cerebral venous thrombosis, and other vascular intracranial disturbances. Handb Clin Neurol. 2010;97:529–40. doi:10.1016/s0072-9752(10)97048-6.CrossRefPubMed

17.

Jamieson DG, Cheng NT, Skliut M. Headache and acute stroke. Curr Pain Headache Rep. 2014;18(9):444. doi:10.1007/s11916-014-0444-1.CrossRef

18.

Wang YX, Le WD. Progress in Diagnosing Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-like Episodes. Chin Med J (Engl). 2015;128(13):1820–5. doi:10.4103/0366-6999.159360.CrossRef

19.

Kim IO, Kim JH, Kim WS, Hwang YS, Yeon KM, Han MC. Mitochondrial myopathy-encephalopathy-lactic acidosis-and strokelike episodes (MELAS) syndrome: CT and MR findings in seven children. AJR Am J Roentgenol. 1996;166(3):641–5. doi:10.2214/ajr.166.3.8623642.CrossRefPubMed

20.

Chung SH, Chen SC, Chen WJ, Lee CC. Symmetric basal ganglia calcification in a 9-year-old child with MELAS. Neurology. 2005;65(9), E19. doi:10.1212/01.wnl.0000184112.34211.d1.CrossRefPubMed

21.

Hirano M, Pavlakis SG. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS): current concepts. J Child Neurol. 1994;9(1):4–13.CrossRefPubMed

22.

Davis PC, Hoffman Jr JC, Braun IF, Ahmann P, Krawiecki N. MR of Leigh’s disease (subacute necrotizing encephalomyelopathy). AJNR Am J Neuroradiol. 1987;8(1):71–5.PubMed

23.

Goodfellow JA, Dani K, Stewart W, Santosh C, McLean J, Mulhern S, et al. Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes: an important cause of stroke in young people. Postgrad Med J. 2012;88(1040):326–34. doi:10.1136/postgradmedj-2011-130326.CrossRefPubMed

24.

Gire C, Girard N, Nicaise C, Einaudi MA, Montfort MF, Dejode JM. Clinical features and neuroradiological findings of mitochondrial pathology in six neonates. Childs Nerv Syst. 2002;18(11):621–8. doi:10.1007/s00381-002-0621-0.CrossRefPubMed

25.

Moroni I, Bugiani M, Bizzi A, Castelli G, Lamantea E, Uziel G. Cerebral white matter involvement in children with mitochondrial encephalopathies. Neuropediatrics. 2002;33(2):79–85. doi:10.1055/s-2002-32372.CrossRefPubMed

26.

Pauli W, Zarzycki A, Krzysztalowski A, Walecka A. CT and MRI imaging of the brain in MELAS syndrome. Pol J Radiol. 2013;78(3):61–5. doi:10.12659/pjr.884010.CrossRefPubMedPubMedCentral

27.

Wang XY, Noguchi K, Takashima S, Hayashi N, Ogawa S, Seto H. Serial diffusion-weighted imaging in a patient with MELAS and presumed cytotoxic oedema. Neuroradiology. 2003;45(9):640–3. doi:10.1007/s00234-003-1029-6.CrossRefPubMed

28.

Yoneda M, Maeda M, Kimura H, Fujii A, Katayama K, Kuriyama M. Vasogenic edema on MELAS: a serial study with diffusion-weighted MR imaging. Neurology. 1999;53(9):2182–4.CrossRefPubMed

29.

Jian-Ren L. Precipitation of stroke-like event by chickenpox in a child with MELAS syndrome. Neurol India. 2005;53(3):323–5.CrossRefPubMed

30.

Yonemura K, Hasegawa Y, Kimura K, Minematsu K, Yamaguchi T. Diffusion-weighted MR imaging in a case of mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes. AJNR Am J Neuroradiol. 2001;22(2):269–72.PubMed

31.

Tzoulis C, Bindoff LA. Serial diffusion imaging in a case of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes. Stroke. 2009;40(2):e15–7. doi:10.1161/strokeaha.108.523118.CrossRefPubMed

32.

Kim JH, Lim MK, Jeon TY, Rha JH, Eo H, Yoo SY, et al. Diffusion and perfusion characteristics of MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episode) in thirteen patients. Korean J Radiol. 2011;12(1):15–24. doi:10.3348/kjr.2011.12.1.15.CrossRefPubMedPubMedCentral

33.

Chinnery PF. Mitochondrial Disorders Overview. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, editors. GeneReviews(R). Seattle (WA): University of Washington, Seattle; 1993. All rights reserved.

34.

Dindyal S, Mistry K, Angamuthu N, Smith G, Hilton D, Arumugam P, et al. MELAS syndrome presenting as an acute surgical abdomen. Ann R Coll Surg Engl. 2014;96(1):101e–3e. doi:10.1308/003588414x13824511649733.CrossRefPubMed

35.

Saneto RP, Friedman SD, Shaw DW. Neuroimaging of mitochondrial disease. Mitochondrion. 2008;8(5–6):396–413. doi:10.1016/j.mito.2008.05.003.CrossRefPubMedPubMedCentral

36.

Wilichowski E, Pouwels PJ, Frahm J, Hanefeld F. Quantitative proton magnetic resonance spectroscopy of cerebral metabolic disturbances in patients with MELAS. Neuropediatrics. 1999;30(5):256–63. doi:10.1055/s-2007-973500.CrossRefPubMed

37.

Moller HE, Kurlemann G, Putzler M, Wiedermann D, Hilbich T, Fiedler B. Magnetic resonance spectroscopy in patients with MELAS. J Neurol Sci. 2005;229–230:131–9. doi:10.1016/j.jns.2004.11.014.CrossRefPubMed

38.

Osborn AG, Salzman KL, Jhaveri MD, Barkovich AJ. Diagnostic imaging: brain. Elsevier Health Sciences; 2015

39.

Abe K, Yoshimura H, Tanaka H, Fujita N, Hikita T, Sakoda S. Comparison of conventional and diffusion-weighted MRI and proton MR spectroscopy in patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like events. Neuroradiology. 2004;46(2):113–7. doi:10.1007/s00234-003-1138-2.CrossRefPubMed

40.

Kaufmann P, Engelstad K, Wei Y, Kulikova R, Oskoui M, Sproule DM, et al. Natural history of MELAS associated with mitochondrial DNA m.3243A>G genotype. Neurology. 2011;77(22):1965–71. doi:10.1212/WNL.0b013e31823a0c7f.CrossRefPubMedPubMedCentral

41.

Weiduschat N, Kaufmann P, Mao X, Engelstad KM, Hinton V, DiMauro S, et al. Cerebral metabolic abnormalities in A3243G mitochondrial DNA mutation carriers. Neurology. 2014;82(9):798–805. doi:10.1212/wnl.0000000000000169.CrossRefPubMedPubMedCentral

42.

Virtanen SM, Lindroos MM, Majamaa K, Nuutila P, Borra RJ, Parkkola R. Voxelwise analysis of diffusion tensor imaging and structural MR imaging in patients with the m.3243A>G mutation in mitochondrial DNA. AJNR Am J Neuroradiol. 2011;32(3):522–6. doi:10.3174/ajnr.A2309.CrossRefPubMed

43.

Noguchi A, Shoji Y, Matsumori M, Komatsu K, Takada G. Stroke-like episode involving a cerebral artery in a patient with MELAS. Pediatr Neurol. 2005;33(1):70–1. doi:10.1016/j.pediatrneurol.2005.01.013.CrossRefPubMed

44.

Iizuka T, Goto Y, Miyakawa S, Sato M, Wang Z, Suzuki K, et al. Progressive carotid artery stenosis with a novel tRNA phenylalanine mitochondrial DNA mutation. J Neurol Sci. 2009;278(1–2):35–40. doi:10.1016/j.jns.2008.11.016.CrossRefPubMed

45.

Ooiwa Y, Uematsu Y, Terada T, Nakai K, Itakura T, Komai N, et al. Cerebral blood flow in mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes. Stroke. 1993;24(2):304–9.CrossRefPubMed

46.

Molnar MJ, Valikovics A, Molnar S, Tron L, Dioszeghy P, Mechler F, et al. Cerebral blood flow and glucose metabolism in mitochondrial disorders. Neurology. 2000;55(4):544–8.CrossRefPubMed

47.

Ikawa M, Okazawa H, Arakawa K, Kudo T, Kimura H, Fujibayashi Y, et al. PET imaging of redox and energy states in stroke-like episodes of MELAS. Mitochondrion. 2009;9(2):144–8. doi:10.1016/j.mito.2009.01.011.CrossRefPubMed

48.

Nishioka J, Akita Y, Yatsuga S, Katayama K, Matsuishi T, Ishibashi M, et al. Inappropriate intracranial hemodynamics in the natural course of MELAS. Brain Dev. 2008;30(2):100–5. doi:10.1016/j.braindev.2007.06.008.CrossRefPubMed

49.

Thajeb P, Wu MC, Shih BF, Tzen CY, Chiang MF, Yuan RY. Brain single photon emission computed tomography in patients with A3243G mutation in mitochondrial DNA tRNA. Ann N Y Acad Sci. 2005;1042:48–54. doi:10.1196/annals.1338.005.CrossRefPubMed

50.

Koga Y, Akita Y, Junko N, Yatsuga S, Povalko N, Fukiyama R, et al. Endothelial dysfunction in MELAS improved by l-arginine supplementation. Neurology. 2006;66(11):1766–9. doi:10.1212/01.wnl.0000220197.36849.1e.CrossRefPubMed

51.

Koga Y, Povalko N, Nishioka J, Katayama K, Kakimoto N, Matsuishi T. MELAS and L-arginine therapy: pathophysiology of stroke-like episodes. Ann N Y Acad Sci. 2010;1201:104–10. doi:10.1111/j.1749-6632.2010.05624.x.CrossRefPubMed

52.

Iizuka T, Sakai F, Kan S, Suzuki N. Slowly progressive spread of the stroke-like lesions in MELAS. Neurology. 2003;61(9):1238–44.CrossRefPubMed

53.

Tsujikawa T, Yoneda M, Shimizu Y, Uematsu H, Toyooka M, Ikawa M, et al. Pathophysiologic evaluation of MELAS strokes by serially quantified MRS and CASL perfusion images. Brain Dev. 2010;32(2):143–9. doi:10.1016/j.braindev.2008.12.003.CrossRefPubMed

54.

Ikawa M, Yoneda M, Muramatsu T, Matsunaga A, Tsujikawa T, Yamamoto T, et al. Detection of preclinically latent hyperperfusion due to stroke-like episodes by arterial spin-labeling perfusion MRI in MELAS patients. Mitochondrion. 2013;13(6):676–80. doi:10.1016/j.mito.2013.09.007.CrossRefPubMed

55.

Huppi PS, Inder TE. Magnetic resonance techniques in the evaluation of the perinatal brain: recent advances and future directions. Semin Neonatol. 2001;6(2):195–210. doi:10.1053/siny.2001.0039.CrossRefPubMed

56.

Majoie CB, Akkerman EM, Blank C, Barth PG, Poll-The BT, den Heeten GJ. Mitochondrial encephalomyopathy: comparison of conventional MR imaging with diffusion-weighted and diffusion tensor imaging: case report. AJNR Am J Neuroradiol. 2002;23(5):813–6.PubMed

57.•

Xie S. MR OEF, imaging in MELAS. Methods Enzymol. 2014;547:433–44. doi:10.1016/b978-0-12-801415-8.00021-7.CrossRefPubMed

58.

De Volder A, Ghilain S, de Barsy T, Goffinet AM. Brain metabolism in mitochondrial encephalomyopathy: a PET study. J Comput Assist Tomogr. 1988;12(5):854–7.CrossRefPubMed

59.

Yu L, Xie S, Xiao J, Wang Z, Zhang X. Quantitative measurement of cerebral oxygen extraction fraction using MRI in patients with MELAS. PLoS One. 2013;8(11):e79859. doi:10.1371/journal.pone.0079859.CrossRefPubMedPubMedCentral

60.

Malhotra K, Conners JJ, Lee VH, Prabhakaran S. Relative changes in transcranial Doppler velocities are inferior to absolute thresholds in prediction of symptomatic vasospasm after subarachnoid hemorrhage. J Stroke Cerebrovasc Dis. 2014;23(1):31–6. doi:10.1016/j.jstrokecerebrovasdis.2012.08.004.CrossRefPubMed

61.

Kodaka R, Itagaki Y, Matsumoto M, Nagai T, Okada S. A transcranial doppler ultrasonography study of cerebrovascular CO2 reactivity in mitochondrial encephalomyopathy. Stroke. 1996;27(8):1350–3.CrossRefPubMed

62.

Ganslandt O, Steinmeier R, Kober H, Vieth J, Kassubek J, Romstock J, et al. Magnetic source imaging combined with image-guided frameless stereotaxy: a new method in surgery around the motor strip. Neurosurgery. 1997;41(3):621–7. discussion 7–8.

63.

Rossini PM, Tecchio F, Pizzella V, Lupoi D, Cassetta E, Pasqualetti P, et al. On the reorganization of sensory hand areas after mono-hemispheric lesion: a functional (MEG)/anatomical (MRI) integrative study. Brain Res. 1998;782(1–2):153–66.CrossRefPubMed

64.

Kamada K, Takeuchi F, Houkin K, Kitagawa M, Kuriki S, Ogata A, et al. Reversible brain dysfunction in MELAS: MEG, and (1)H MRS analysis. J Neurol Neurosurg Psychiatry. 2001;70(5):675–8.CrossRefPubMedPubMedCentral

65.••

Tschampa HJ, Urbach H, Greschus S, Kunz WS, Kornblum C. Neuroimaging characteristics in mitochondrial encephalopathies associated with the m.3243A>G MTTL1 mutation. J Neurol. 2013;260(4):1071–80. doi:10.1007/s00415-012-6763-4.CrossRefPubMed

66.

Lax NZ, Pienaar IS, Reeve AK, Hepplewhite PD, Jaros E, Taylor RW, et al. Microangiopathy in the cerebellum of patients with mitochondrial DNA disease. Brain. 2012;135(Pt 6):1736–50. doi:10.1093/brain/aws110.CrossRefPubMedPubMedCentral

67.

Renard D, Taieb G. Neurological picture. Cortical susceptibility-weighted imaging hypointensity after stroke-like episode in MELAS. J Neurol Neurosurg Psychiatry. 2014;85(9):1055–6. doi:10.1136/jnnp-2013-306933.CrossRefPubMed

68.

Betts J, Jaros E, Perry RH, Schaefer AM, Taylor RW, Abdel-All Z, et al. Molecular neuropathology of MELAS: level of heteroplasmy in individual neurones and evidence of extensive vascular involvement. Neuropathol Appl Neurobiol. 2006;32(4):359–73. doi:10.1111/j.1365-2990.2006.00731.x.CrossRefPubMed

69.

Ramanathan RS, Malhotra K, Scott T. Teaching NeuroImages: diffuse cerebral neurosarcoidosis mimicking gliomatosis cerebri. Neurology. 2013;81(7):e46. doi:10.1212/WNL.0b013e3182a08d47.

Titel: Imaging of MELAS
verfasst von: Konark Malhotra
David S. Liebeskind
Publikationsdatum: 01.09.2016
Verlag: Springer US
Erschienen in: Current Pain and Headache Reports / Ausgabe 9/2016
Print ISSN: 1531-3433
Elektronische ISSN: 1534-3081
DOI: https://doi.org/10.1007/s11916-016-0583-7

Neu im Fachgebiet AINS

23.04.2024 | Appendizitis | Nachrichten

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren

Springer Medizin

Imaging of MELAS

Abstract

Neu im Fachgebiet AINS

Hinter dieser Appendizitis steckte ein Erreger

Ärztliche Empathie hilft gegen Rückenschmerzen

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

S3-Leitlinie zu Pankreaskrebs aktualisiert

Update AINS

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2016

Opioid Treatment of Migraine: Risk Factors and Behavioral Issues

Evaluation and Management of SCI-Associated Pain

Neuroimaging in the Diagnostic Evaluation of Eye Pain

Neurosurgical Emergencies in Sports Neurology

Neu im Fachgebiet AINS

Hinter dieser Appendizitis steckte ein Erreger

Ärztliche Empathie hilft gegen Rückenschmerzen

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

S3-Leitlinie zu Pankreaskrebs aktualisiert

Update AINS